Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, P.H. Road, Chennai 600077, India.
Department of Biotechnology, DG Vaishnav College, Chennai 600106, India.
Medicina (Kaunas). 2023 Feb 11;59(2):343. doi: 10.3390/medicina59020343.
: The BaeR protein is involved in the adaptation system of and is associated with virulence factors responsible for systemic infections in hospitalized patients. This study was conducted to characterize putative epitope peptides for the design of vaccines against BaeR protein, using an immune-informatic approach. : FASTA sequences of BaeR from five different strains of were retrieved from the UNIPROT database and evaluated for their antigenicity, allergenicity and vaccine properties using BepiPred, Vaxijen, AlgPred, AntigenPro and SolPro. Their physio-chemical properties were assessed using the Expasy Protparam server. Immuno-dominant B-cell and T-cell epitope peptides were predicted using the IEDB database and MHC cluster server with a final assessment of their interactions with TLR-2. Results: A final selection of two peptide sequences (36aa and 22aa) was made from the 38 antigenic peptides. E1 was considered a soluble, non-allergenic antigen, and possessed negative GRAVY values, substantiating the hydrophilic nature of the proteins. Further analysis on the T-cell epitopes, class I immunogenicity and HLA allele frequencies yielded T-cell immuno-dominant peptides. The protein-peptide interactions of the TLR-2 receptor showed good similarity scores in terms of the high number of hydrogen bonds compared to other protein-peptide interactions. : The two epitopes predicted from in the present investigation are promising vaccine candidates for targeting the TCS of in systemic and nosocomial infections. This study also demonstrates an alternative strategy to tackling and mitigating MDR strains of and provides a useful reference for the design and construction of novel vaccine candidates against this bacteria.
BaeR 蛋白参与 适应系统,与导致住院患者全身感染的毒力因子有关。本研究旨在使用免疫信息学方法,针对 BaeR 蛋白设计疫苗,对假定的表位肽进行特征描述。
从 UNIPROT 数据库中检索了来自 5 种不同菌株的 BaeR 的 FASTA 序列,并使用 BepiPred、Vaxijen、AlgPred、AntigenPro 和 SolPro 评估它们的抗原性、变应原性和疫苗特性。使用 Expasy Protparam 服务器评估它们的理化性质。使用 IEDB 数据库和 MHC 簇服务器预测免疫优势 B 细胞和 T 细胞表位肽,并使用 TLR-2 进行最终评估。
从 38 个抗原肽中选择了两个肽序列(36aa 和 22aa)。E1 被认为是一种可溶性、非变应原性抗原,具有负的 GRAVY 值,证实了蛋白质的亲水性。对 T 细胞表位、I 类免疫原性和 HLA 等位基因频率进行进一步分析,得出 T 细胞免疫优势肽。TLR-2 受体的蛋白-肽相互作用在氢键数量方面与其他蛋白-肽相互作用具有很好的相似性评分。
本研究从 中预测的两个表位是针对全身和医院感染中 TCS 的有希望的疫苗候选物。该研究还展示了一种针对 MDR 菌株的替代策略,并为针对该细菌设计和构建新型疫苗候选物提供了有用的参考。